Bushenjianpi Formula Combined With Entecavir for HBeAg-negative Chronic Hepatitis B Patients: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet - United Kingdom
doi 10.1016/s0140-6736(16)31960-2
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2016
Authors
Publisher
Elsevier BV